ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

Advancing Native Mass Spectrometry Analysis with Easier, Faster and More Accurate Intact Mass Deconvolution for Proteins and Nucleic Acids

Completed
Institution
MASSMATRIX, INC., OH
Principal investigator
Michael A. Freitas
Funding
$317K
Duration
2025–2026

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY / ABSTRACT This research proposal aims to advance the field of native mass spectrometry (MS) analysis by developing an innovative intact mass deconvolution method designed to significantly improve the speed, accuracy, and user- friendliness of proteins and nucleic acid molecular weight determination. Despite the pivotal role of MS in pharmaceutical research and biopharmaceutical applications, existing challenges such as data artifacts, slow processing speeds, and the complexity of spectral analysis tools hinder its full potential. Our project is organized into three primary aims: 1) To implement enhanced deconvolution techniques that reduce artifacts and optimize processing speed without sacrificing accuracy; 2) To automate spectrum reconstruction for efficient handling of diverse analytical needs; and 3) To conduct a comprehensive performance evaluation of our method against current leading technologies. Through these efforts, we anticipate addressing critical gaps in MS analysis and facilitating deeper insights into the molecular mechanisms underlying health and disease. The outcome of this research promises to redefine the capabilities of mass spectrometry in modern biomedical research, offering a powerful tool for the scientific community to unravel the complexities of biological molecules.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESSpecial Emphasis Panel[ZRG1 MCST-J (10)]R41deconvolutionartifactsnucleicintactmass spectrometryspectrometryspeedmass

Questions for Massmatrix, Inc.

Massmatrix, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.

Same researchers, same topic, scored first.